Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Microbial contamination

Bacteria, mold, yeast or other microorganisms detected in the product. Contamination can occur from water systems, equipment or handling, and can cause infection.

1,002 FDA drug recalls with this cause, newest first.

These recalls involve bacteria, mold, yeast or other microorganisms actually found in the finished product. This overlaps with sterility issues but is tracked separately because it usually points to a specific breakdown - a water system, an unsealed container, a contaminated raw material - rather than a general process failure. It carries a large share of Class I recalls: an organism such as Burkholderia cepacia or Pseudomonas in an eye drop, nasal spray or oral liquid can cause serious infection.

Class II · Moderate risk

Rugby Diocto Liquid

Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination The Harvard Drug Group D-1119-2017
Class II · Moderate risk

Magnesium Citrate Oral Solution

Microbial contamination of non-sterile products: product was found to contain mold, identified as Rhinocladiella similis.

Terminated Microbial contamination Vi-Jon, Inc. NDC 50804-686-38 D-1054-2017
Class II · Moderate risk

Lactulose Solution

Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-038-01 D-1053-2017
Class II · Moderate risk

Lactulose Solution

Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-038-50 D-1052-2017
Class II · Moderate risk

NasalCrom (cromolyn sodium)

CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.

Terminated Microbial contamination Bausch & Lomb, Inc. D-0899-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-208-20 D-0622-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3953-09 D-0621-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3952-09 D-0620-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3951-09 D-0619-2017
Class II · Moderate risk

Atorvastatin Calcium Tablets

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Terminated Microbial contamination Mylan Pharmaceuticals Inc. NDC 0378-3950-77 D-0618-2017
Class II · Moderate risk

Double Hyaluronic 1000

Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.

Ongoing Microbial contamination Signature Club A Ltd D-0662-2017
Class II · Moderate risk

Lactulose Solution

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0463-2017
Class II · Moderate risk

Lactulose Solution

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0462-2017
Class II · Moderate risk

Nystatin Oral Suspension

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-037-99 D-0461-2017
Class II · Moderate risk

Phenytoin Oral Suspension

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0460-2017
Class II · Moderate risk

Metoclopramide Oral Solution

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. D-0459-2017
Class II · Moderate risk

Nystatin Oral Suspension

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-008-02 D-0457-2017